Flagellin attenuates experimental sepsis in a macrophage-dependent manner

Abstract Background Sepsis is the leading cause of death among critically ill patients, and no specific therapeutic agent is currently approved for the treatment of sepsis. Methods We assessed the effects of flagellin administration on survival, bacterial burden, and tissue injury after sepsis. In a...

Full description

Bibliographic Details
Main Authors: Xiaoliang Yang, Yibing Yin, Xingxing Yan, Zebo Yu, Yi Liu, Ju Cao
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Critical Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13054-019-2408-7